TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Health Care Sector IconHealth Care

TD Cowen strives to outperform as the health care destination for capital markets solutions, strategic advice and research coverage by combining global resources with focused, full-service product capabilities.

Start a Conversation

Life sciences investment banking
Focused on Innovation

With an industry focused on enhancing patient care and clinical outcomes, TD Cowen’s Health Care franchise is similarly aligned and focused on companies who are poised to outperform for patients. We combine global resources and full-service product capabilities with the focus and commitment of a specialty investment banking firm powered by our agenda-setting research.

Our areas of Health Care expertise include:

  • Biotechnology
  • Digital Therapeutics
  • Health Care Facilities
  • Health Care Services
  • Health Care Technology
  • Life Science & Diagnostic Tools
  • Managed Care
  • Medical Supplies & Devices
  • Pharmaceuticals – Major

 

If you would like further information about how our capabilities can support your investment goals, start a conversation below.

Female scientist in a biotech lab
Leading with Insights

We are in the golden age of a scientific innovation, with emerging science and technology that is rapidly advancing the Health Care industry and landscape. TD Cowen is focused on being at the crossroads of this innovation through a suite of products and industry events:

  • Our Ahead of The Curve® Series captures unique insights on emerging topics or themes;
  • Our award-winning equity research analysts have been recognized in third-party polls, such as Institutional Investor’s All-America Research Team, the Greenwich Associates poll and Starmine.
  • Our annual Health Care Conference is one of most highly regards events for Health Care on Wall Street, best recognized for thought-provoking panels and insights from industry experts
Cowen Equity Research Biotechnology Brochure
Kyber

Kyber’s highly unique, nationally-representative health care claims & EMR data product enables timely and accurate analyses across health care subsectors including for drug, medical device, diagnostics and facilities companies. Transaction-level data allow buyers to develop a large number of KPIs and drive granular insights into the dynamics of product revenue & disease dynamics.

Recent Transactions

Mar 2024

Exchange of all Outstanding Series B Convertible Preferred Stock for Common Stock

Financial Advisor

View Details >
Mar 2024
$600 Million

Follow-on Offering

Bookrunner

View Details >
Mar 2024
$150 Million

Underwritten Offering

Lead Left Bookrunner

View Details >